Reliable Compounding Pharmacy Recalls Squaric Acid Products Due to Processing Controls
Reliable Compounding Pharmacy is recalling all squaric acid products due to a lack of processing controls. The recall covers lots compounded between March 2015 and March 2016.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source text cites 'Lack of Processing Controls' as the reason, which is a quality control issue that may lead to product variability but does not explicitly state reported illnesses or injuries, fitting the Moderate severity criteria for low-risk contamination or voluntary precautionary recalls.
Plain-English summary
Reliable Rexall-A Compounding Pharmacy is recalling all squaric acid products, which are prescription-only medications. The recall is being conducted due to a lack of processing controls.
The affected products were compounded by Reliable Drug/Reliable Compounding Pharmacy located in San Francisco, California. The recall includes all lots compounded between March 24, 2015, and March 24, 2016, that are within their expiration dates. These products were distributed in the United States, specifically in California, Hawaii, and New Mexico.
Consumers who have these products should stop using them and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- All squaric acid Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.
- Manufacturer
- Reliable Rexall-A Compounding Pharmacy
- Category
- Drug — Compounded Prescription
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots compounded between 03/24/2015 and 03/24/2016 and within expiry.
Distribution
Part of a larger recall action
This product is one of 70 recalled by Reliable Rexall-A Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 70 products in this recall →Related recalls
Same manufacturer · Reliable Rexall-A Compounding Pharmacy
See all →- HighReliable Compounding Pharmacy Recalls Diltiazem Products Due to Processing Controls
FDA (Drugs) · 2016-07-13
- ModerateReliable Drug Recalls Compounded All Midrin Products Due to Processing Controls
FDA (Drugs) · 2016-07-13
- ModerateReliable Drug Recalls Compounded Monobenzone Products Due to Processing Controls
FDA (Drugs) · 2016-07-13
- ModerateReliable Drug Recalls Quinacrine Products Due to Processing Control Deficiencies
FDA (Drugs) · 2016-07-13
- Moderate
Same hazard · processing controls
See all →- HighCompounded tirzepatide 8.8 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 11.24 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.22 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.44 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 4.4 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
Similar recalls
- SevereSpecialty Compounding Recalls All Prescription Products Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- SevereAbbott's Compounding Pharmacy Recalls Folic Acid Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Calcium Compounds for Sterility Concerns
FDA (Drugs) · 2016-02-24
- Severe
- Moderate
- SevereUS Compounding Recalls Succinylcholine Chloride Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-25